Choi, H.S.; Ko, Y.S.; Jin, H.; Kang, K.M.; Ha, I.B.; Jeong, H.; Lee, J.-h.; Jeong, B.K.; Kim, H.J.
Mebendazole Increases Anticancer Activity of Radiotherapy in Radiotherapy-Resistant Triple-Negative Breast Cancer Cells by Enhancing Natural Killer Cell-Mediated Cytotoxicity. Int. J. Mol. Sci. 2022, 23, 15493.
https://doi.org/10.3390/ijms232415493
AMA Style
Choi HS, Ko YS, Jin H, Kang KM, Ha IB, Jeong H, Lee J-h, Jeong BK, Kim HJ.
Mebendazole Increases Anticancer Activity of Radiotherapy in Radiotherapy-Resistant Triple-Negative Breast Cancer Cells by Enhancing Natural Killer Cell-Mediated Cytotoxicity. International Journal of Molecular Sciences. 2022; 23(24):15493.
https://doi.org/10.3390/ijms232415493
Chicago/Turabian Style
Choi, Hoon Sik, Young Shin Ko, Hana Jin, Ki Mun Kang, In Bong Ha, Hojin Jeong, Jeong-hee Lee, Bae Kwon Jeong, and Hye Jung Kim.
2022. "Mebendazole Increases Anticancer Activity of Radiotherapy in Radiotherapy-Resistant Triple-Negative Breast Cancer Cells by Enhancing Natural Killer Cell-Mediated Cytotoxicity" International Journal of Molecular Sciences 23, no. 24: 15493.
https://doi.org/10.3390/ijms232415493
APA Style
Choi, H. S., Ko, Y. S., Jin, H., Kang, K. M., Ha, I. B., Jeong, H., Lee, J. -h., Jeong, B. K., & Kim, H. J.
(2022). Mebendazole Increases Anticancer Activity of Radiotherapy in Radiotherapy-Resistant Triple-Negative Breast Cancer Cells by Enhancing Natural Killer Cell-Mediated Cytotoxicity. International Journal of Molecular Sciences, 23(24), 15493.
https://doi.org/10.3390/ijms232415493
